IBM’s Reckoning: A Historic One-Day Rout, a Legal Onslaught, and the Case for Calm
Published on 07/31/2026 at 13:21 | Redaktion boerse-global.de
The numbers are brutal by any measure. IBM’s stock has shed roughly a third of its value since early June, and the company is now navigating the most turbulent stretch in its history as a public company. Yet beneath the wreckage of a catastrophic earnings warning, a more nuanced picture is emerging — one that pits a wave of shareholder litigation against signs that the market may have overcorrected.
The Day Everything Changed
July 14 will be remembered as the worst trading session IBM has ever endured. The stock collapsed by more than 25 percent in a single day — a decline that surpassed even the infamous crash of October 19, 1987, when shares fell 23.7 percent. The trigger was a preliminary second-quarter report that came in well below expectations, and the scale of the damage caught even seasoned market watchers off guard. CNBC subsequently confirmed what many suspected: it was the largest single-day percentage loss in the stock’s history.
The final numbers, released on July 22, essentially confirmed the preliminary picture without making it worse. Adjusted earnings per share came in at $2.93 against a consensus estimate of $2.97, while revenue reached $17.16 billion versus the $17.58 billion analysts had penciled in — growth of just 1 percent year over year. The infrastructure division bore the brunt of the pain, with revenue sliding 7 percent to $3.84 billion. Within that segment, mainframe sales tied to the Z-system collapsed by a staggering 42 percent.
Management responded by trimming its full-year outlook, now guiding for constant-currency revenue growth of 4 to 5 percent, down from the more optimistic forecast offered in April. Notably, the company reaffirmed its target of $1 billion in additional free cash flow for the year.
Should investors sell immediately? Or is it worth buying IBM?
The Legal Storm Gathers
The scale of the rout has attracted the attention of plaintiff firms, and the drumbeat of investigations is growing louder. Bleichmar Fonti & Auld LLP issued a fresh reminder to shareholders on July 29, following a similar notice the previous day, as it continues to probe potential securities fraud tied to weakness in the Z-mainframe business. The firm has zeroed in on whether management misled investors about the health of the mainframe segment and the trajectory of new business deals.
Hagens Berman also announced on July 28 that it is examining possible violations of U.S. securities law. These efforts build on earlier inquiries launched by BFA Law in mid-July. The pattern is familiar: after a violent price collapse, law firms circle, and the question is not whether a formal class action will emerge, but when. Two weeks after the initial shock, the legal pressure shows no sign of abating.
A CEO’s Defense
Arvind Krishna, IBM’s chief executive, has been publicly pushing back against the narrative that the company’s problems are structural. In an appearance on Fox Business, he argued that a third of the large deals deferred in the second quarter have already returned. His explanation points to external forces rather than internal decay: a sharp rise in semiconductor prices prompted corporate clients to redirect budgets toward physical servers at the expense of software purchases. Those postponed deals, he insists, are coming back.
CFO Jim Kavanaugh has mounted a parallel defense of the mainframe franchise, telling Yahoo Finance: “We see no evidence that customers are migrating away from the mainframe.”
The market’s reaction to the final earnings release offers some support for that view. In the run-up to the official report, shares fell just 2.15 percent, followed by a modest 0.22 percent decline in after-hours trading. That muted response suggests investors had already priced in the bad news weeks earlier — a signal that the panic phase may have largely run its course.
The Bull Case Hiding in Plain Sight
For all the gloomy headlines, several segments continue to deliver. Software, IBM’s most profitable business, generated $7.76 billion in revenue, up 5 percent year over year. Hybrid Cloud, driven primarily by Red Hat OpenShift, grew 11 percent, with OpenShift’s annual recurring revenue reaching $2.2 billion. The data segment expanded 19 percent, fueled by demand for AI-driven analytics.
Consulting, meanwhile, shows encouraging momentum beneath the surface. New bookings grew 6 percent for the second consecutive quarter, and generative AI now accounts for roughly half of all new engagements and over 30 percent of the backlog.
Technical indicators also support a contrarian reading. The relative strength index sits at 39.4 — approaching oversold territory without having reached the capitulation stage. The stock trades 15.81 percent below its 50-day moving average and 17.41 percent below its 200-day average, gaps that historically tend to narrow once selling pressure abates.
Wall Street appears to share some of that conviction. The consensus price target stands at €212.87, implying upside of roughly 10.7 percent from current levels. Of the twelve analysts who have weighed in over the past three months, six rate the stock a buy, five say hold, and only one recommends selling — a “Moderate Buy” consensus that suggests the selloff has pushed the valuation below fair value.
IBM at a turning point? This analysis reveals what investors need to know now.
The Bear Case Can’t Be Dismissed
Skeptics have legitimate concerns. The legal investigations alone could cap sentiment regardless of how fundamentals evolve. The balance sheet has also become less flexible: at the end of June, IBM carried $65.27 billion in debt against just $8.13 billion in cash and marketable securities. First-half acquisitions consumed $10.5 billion — deals that could strengthen the software portfolio but also complicate integration and strain financial headroom.
The stock currently trades 34.36 percent below its 52-week high, and annualized volatility hovers near 86 percent. That is not a profile for the faint of heart.
Where Things Stand
Shares closed Thursday at €192.24, down 2.89 percent on the day, bringing the year-to-date loss to 26.03 percent. The stock remains roughly 34 percent below its June peak of €292.85.
The coming weeks will be telling on two fronts. Legally, the question is whether the investigations crystallize into a formal class action — a familiar trajectory after dramatic price collapses. Operationally, all eyes turn to the third quarter, where Krishna’s promised returning deals must translate into actual revenue. If the capital expenditure shift toward memory chips and servers reverses as supply constraints ease, the deferred software and consulting contracts may simply arrive a few quarters late rather than vanish entirely.
The market has clearly punished IBM for what management frames as a timing problem rather than a broken growth story. Whether that distinction holds will determine if this historic selloff marks a genuine inflection point or the beginning of a deeper decline.
Ad
IBM Stock: New Analysis - 31 July
Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
